Treadwell Therapeuticsincis A Clinical Stage Biotechnology Company Based In New Yorkwith An Additional Presence In Torontofounded In 2019The Company Focuses On Developing Innovative Therapeutics For Aggressive Cancersaddressing Significant Unmet Needs In Cancer Treatmentthe Leadership Team Includes Experienced Professionals From Various Fieldsensuring A Strong Foundation For The Company S Mission The Company Has A Diverse Drug Development Pipeline That Features Small Molecule Drugsbiologicsand T Cell Receptor Based Cell Therapieskey Candidates Include Ocifisertiba Plk4 Inhibitor For Myelodysplastic Syndromesand Cfi 402411An Hpk1 Inhibitor Targeting Advanced Malignant Solid Neoplasmsboth Currently In Phase 1 2 Clinical Trialstreadwell Therapeutics Employs A Science First Approachutilizing Deep Mechanistic Insights To Identify Novel Therapeutic Targets And Streamline The Transition From Scientific Concepts To Clinical Applications
No conferences found for this company.
| Company Name | Treadwell Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
